Trials / Completed
CompletedNCT00649116
Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg
Single-Dose Food In Vivo Bioequivalence Study of Metoprolol Tartrate Tablets (100 mg; Mylan) and Lopressor® (100 mg; Novartis) in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Mylan Pharmaceuticals Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to investigate the bioequivalence of Mylan's metoprolol tartrate tablets to Novartis's Lopressor® tablets following a single, oral 100 mg (1 x 100 mg) dose administered under fed conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metoprolol Tartrate Tablets 100 mg | 100mg, single dose fed |
| DRUG | Lopressor® Tablets 100 mg | 100mg, single dose fed |
Timeline
- Start date
- 2002-12-01
- Primary completion
- 2002-12-01
- Completion
- 2003-01-01
- First posted
- 2008-04-01
- Last updated
- 2024-04-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00649116. Inclusion in this directory is not an endorsement.